TGFB1 and non-small cell lung carcinoma: Emerging evidence indicated that lncRNA Xist is associated with cisplatin resistance in NSCLC by TGF-β effector SMAD2 signaling pathway, miRNA-144-3p/MDR1 and MRP1, and miR-17/ATG7 axis (Sun W. et al., 2017; Tian et al., 2019; Xu et al., 2020).